Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16421
Title: | Ligand-dependent modulation of G protein conformation alters drug efficacy | Austin Authors: | Furness, Sebastian GB;Liang, Yi-Lynn;Nowell, Cameron J;Halls, Michelle L;Wookey, Peter J ;Dal Maso, Emma;Inoue, Asuka;Christopoulos, Arthur;Wootten, Denise;Sexton, Patrick M | Affiliation: | Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan Japan Science and Technology Agency (JST), Precursory Research for Embryonic Sciences and Technology (PRESTO), Kawaguchi, Saitama, Japan |
Issue Date: | 20-Oct-2016 | Date: | 2016-10-06 | Publication information: | Cell 2016; 167(3): 739-749 | Abstract: | G protein-coupled receptor (GPCR) signaling, mediated by hetero-trimeric G proteins, can be differentially controlled by agonists. At a molecular level, this is thought to occur principally via stabilization of distinct receptor conformations by individual ligands. These distinct conformations control subsequent recruitment of transducer and effector proteins. Here, we report that ligand efficacy at the calcitonin GPCR (CTR) is also correlated with ligand-dependent alterations to G protein conformation. We observe ligand-dependent differences in the sensitivity of the G protein ternary complex to disruption by GTP, due to conformational differences in the receptor-bound G protein hetero-trimer. This results in divergent agonist-dependent receptor-residency times for the hetero-trimeric G protein and different accumulation rates for downstream second messengers. This study demonstrates that factors influencing efficacy extend beyond receptor conformation(s) and expands understanding of the molecular basis for how G proteins control/influence efficacy. This has important implications for the mechanisms that underlie ligand-mediated biased agonism. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16421 | DOI: | 10.1016/j.cell.2016.09.021 | ORCID: | 0000-0002-3937-1621 | Journal: | Cell | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/27720449 | Type: | Journal Article | Subjects: | BRET CTR FRET G protein-coupled receptor GPCR Calcitonin Calcitonin receptor TIRF Efficacy Native PAGE |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.